To my mind, JAK has all the ingredients to be a real winner. Good address, good management, not too many shares, diverse projects. I have small stake...
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025